Free Trial

Tourmaline Bio (TRML) Earnings Date, Estimates & Call Transcripts

Tourmaline Bio logo
$19.66 +0.93 (+4.94%)
As of 02:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Tourmaline Bio Earnings Summary

Tourmaline Bio released Q1 2025 earnings on May 2, 2025, reporting an EPS of -$0.89, which topped analysts' consensus estimates of -$0.91 by $0.02. With a trailing EPS of -$3.21, Tourmaline Bio's earnings are expected to decrease next year, from ($3.02) to ($3.56) per share.

Upcoming Q2
Earnings Date
Aug. 14Before Market OpensEstimated
Consensus EPS
(May. 2)
-$0.91
Actual EPS
(May. 2)
-$0.89 Beat By $0.02

Q1 2025 Earnings Resources

TRML Upcoming Earnings

Tourmaline Bio's next earnings date is estimated for Thursday, August 14, 2025, based on past reporting schedules.

Get Tourmaline Bio Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tourmaline Bio and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

TRML Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Tourmaline Bio Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20252-$0.85-$0.85-$0.85
Q2 20253-$0.97-$0.90-$0.93
Q3 20253-$1.00-$0.74-$0.88
Q4 20253-$0.96-$0.80-$0.89
FY 2025 11 -$3.78 -$3.29 -$3.55
Q1 20261-$0.93-$0.93-$0.93
Q2 20261-$0.94-$0.94-$0.94
Q3 20261-$0.95-$0.95-$0.95
Q4 20261-$0.96-$0.96-$0.96

Tourmaline Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/14/2025
(Estimated)
--------
5/2/2025Q1 2025-$0.91-$0.89+$0.02-$0.89--
3/13/2025Q4 2024-$0.91-$0.86+$0.05-$0.86-$0.04M
11/7/2024--$0.84-$0.78+$0.06-$0.78--
8/8/2024--$0.72-$0.68+$0.04-$0.68--
5/13/2024Q1 2024-$0.68-$0.55+$0.13-$0.55--
3/19/2024Q4 2023-$0.75-$0.81 -$0.06-$0.81--
11/14/2023Q3 2023-$0.94-$1.64 -$0.70-$1.64--
8/14/2023Q2 2023--$2.00 -$2.00-$0.50--

Tourmaline Bio Earnings - Frequently Asked Questions

Tourmaline Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 14th, 2025 based off last year's report dates. Learn more on TRML's earnings history.

In the previous quarter, Tourmaline Bio (NASDAQ:TRML) reported ($0.89) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.91) by $0.02. Learn more on analysts' earnings estimate vs. TRML's actual earnings.

Tourmaline Bio's earnings report can be found in their filing with the SEC.
View SEC filing

Tourmaline Bio (NASDAQ:TRML) has a recorded net income of -$42.12 million. TRML has generated -$3.21 earnings per share over the last four quarters.

Tourmaline Bio's earnings are expected to decrease from ($3.02) per share to ($3.56) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:TRML) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners